SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4fxg'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 8	HIS H 483 ASP H 627 SER H 628 VAL H 653 GLY H 656 GLY H 667	None	0.56A	1aq7A-4fxgH: 32.9	1aq7A-4fxgH: 36.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 9	ASP H 627 VAL H 653 TRP H 655 GLY H 656 GLY H 667	None	0.37A	1bcuH-4fxgH: 36.1	1bcuH-4fxgH: 35.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 12	HIS H 483 ASP H 627 VAL H 653 TRP H 655 GLY H 656 GLY H 667	None	0.55A	1etrH-4fxgH: 34.7	1etrH-4fxgH: 34.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 8	ASP H 627 SER H 628 VAL H 653 GLY H 656 GLY H 667	None	0.36A	1f5lA-4fxgH: 32.9	1f5lA-4fxgH: 31.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTI_E_CCSE47_0 (GLUTATHIONE S-TRANSFERASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 7	THR H 670 LEU H 637 GLY H 635 LEU H 479	None	0.99A	1gtiE-4fxgH: undetectable	1gtiE-4fxgH: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OIP_A_VIVA1278_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	ILE H 652 ILE H 548 ILE H 536 LEU H 538 VAL H 542	None	1.03A	1oipA-4fxgH: undetectable	1oipA-4fxgH: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDU_B_MK1B902_1 (PROTEASE RETROPEPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 11	ALA H 619 GLY H 650 GLY H 651 VAL H 588 ILE H 590	None	0.89A	1sduA-4fxgH: undetectable	1sduA-4fxgH: 14.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 6	ASP H 627 SER H 628 VAL H 653 GLY H 656 GLY H 667	None	0.38A	1tnlA-4fxgH: 33.4	1tnlA-4fxgH: 36.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BR4_B_SAMB301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	LYS H 445 GLY H 631 ASP H 632 ALA H 633 ALA H 481	None	0.91A	2br4B-4fxgH: undetectable	2br4B-4fxgH: 23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BR4_E_SAME301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	LYS H 445 GLY H 631 ASP H 632 ALA H 633 ALA H 481	None	0.89A	2br4E-4fxgH: undetectable	2br4E-4fxgH: 23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2F8L_A_SAMA400_0 (HYPOTHETICAL PROTEIN LMO1582)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	ALA H 636 GLY H 470 LEU H 472 VAL H 653 GLY H 651	None	1.12A	2f8lA-4fxgH: undetectable	2f8lA-4fxgH: 22.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 6	ASP H 627 SER H 628 VAL H 653 GLY H 656 GLY H 667	None	0.33A	2otvA-4fxgH: 33.5	2otvA-4fxgH: 36.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 12	ASP H 627 VAL H 653 TRP H 655 GLY H 656 GLY H 667 TYR H 669	None	0.32A	2p16A-4fxgH: 34.1	2p16A-4fxgH: 34.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 8	ASP H 627 SER H 628 VAL H 653 GLY H 656 GLY H 667	None	0.41A	2vinA-4fxgH: 33.5	2vinA-4fxgH: 31.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 12	ASP H 627 VAL H 653 TRP H 655 GLY H 656 GLY H 667 TYR H 669	None	0.35A	2w26A-4fxgH: 34.0	2w26A-4fxgH: 34.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Z54_A_AB1A200_1 (HIV-1 PROTEASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	GLY H 667 ALA H 619 GLY H 651 VAL H 588 ILE H 590	None	1.05A	2z54A-4fxgH: undetectable	2z54A-4fxgH: 17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ARU_A_PNXA608_1 (CHITINASE A)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 6	TRP H 573 SER H 571 ALA H 570 ASP H 632	None	1.17A	3aruA-4fxgH: undetectable	3aruA-4fxgH: 18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKY_A_DR7A100_1 (PROTEASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 10	GLY H 667 ALA H 619 GLY H 651 VAL H 588 ILE H 590	None	0.95A	3ekyA-4fxgH: undetectable	3ekyA-4fxgH: 16.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 11	HIS H 483 ASP H 627 SER H 628 TRP H 655 GLY H 656 GLY H 667	None	0.59A	3gy3A-4fxgH: 32.8	3gy3A-4fxgH: 36.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_A_SAMA301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	3 / 3	SER H 493 ASP H 491 ASP H 496	None	0.87A	3iv6A-4fxgH: undetectable	3iv6A-4fxgH: 23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_C_SAMC301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	3 / 3	SER H 493 ASP H 491 ASP H 496	None	0.93A	3iv6C-4fxgH: undetectable	3iv6C-4fxgH: 23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KVV_F_URFF254_1 (URIDINE PHOSPHORYLASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 6	GLY H 634 GLN H 459 ILE H 652 VAL H 653	None	1.16A	3kvvF-4fxgH: undetectable	3kvvF-4fxgH: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L8L_D_DVAD8_0 (GRAMICIDIN D)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	3 / 3	VAL H 668 VAL H 653 TRP H 655	None	0.89A	3l8lC-4fxgH: undetectable 3l8lD-4fxgH: undetectable	3l8lC-4fxgH: 5.45 3l8lD-4fxgH: 6.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N3I_A_ROCA201_1 (PROTEASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	ALA H 633 ASP H 632 GLY H 470 ASP H 532 ALA H 482	None	1.22A	3n3iA-4fxgH: undetectable	3n3iA-4fxgH: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NVK_I_SAMI228_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	LYS H 445 GLY H 635 ILE H 652 ALA H 481 ASP H 632	None	1.05A	3nvkI-4fxgH: undetectable	3nvkI-4fxgH: 22.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 6	SER H 628 VAL H 653 TRP H 655 GLY H 656 GLY H 667	None	0.44A	3rxfA-4fxgH: 14.4	3rxfA-4fxgH: 36.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 5	ASP H 627 SER H 628 VAL H 653 GLY H 667	None	0.40A	3rxhA-4fxgH: 33.4	3rxhA-4fxgH: 36.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FFW_A_715A801_2 (DIPEPTIDYL PEPTIDASE 4)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	3 / 3	PHE H 529 TYR H 486 TYR H 523	None	1.00A	4ffwA-4fxgH: undetectable	4ffwA-4fxgH: 15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GBO_B_CUB301_0 (E7)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 5	HIS H 525 ALA H 484 HIS H 483 TYR H 523	None	1.43A	4gboB-4fxgH: undetectable	4gboB-4fxgH: 19.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 12	HIS H 483 ASP H 627 ALA H 633 VAL H 653 TRP H 655 GLY H 667	None	0.54A	4hfpD-4fxgH: 35.0	4hfpD-4fxgH: 35.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J24_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	LEU H 473 LEU H 472 LEU H 538 ILE H 679 ILE H 682	None	1.13A	4j24A-4fxgH: undetectable	4j24A-4fxgH: 20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J24_B_ESTB600_1 (ESTROGEN RECEPTOR BETA)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	LEU H 473 LEU H 472 LEU H 538 ILE H 679 ILE H 682	None	1.11A	4j24B-4fxgH: undetectable	4j24B-4fxgH: 20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Q5M_A_ROCA1101_2 (PROTEASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	ALA H 481 ILE H 652 GLY H 470 VAL H 517 ILE H 536	None	0.99A	4q5mA-4fxgH: undetectable	4q5mA-4fxgH: 22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 10	ALA H 484 ALA H 469 ALA H 633 GLY H 464 THR H 466	None	1.03A	4qvyK-4fxgH: undetectable 4qvyL-4fxgH: undetectable	4qvyK-4fxgH: 24.02 4qvyL-4fxgH: 24.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 10	ALA H 484 ALA H 469 ALA H 633 GLY H 464 THR H 466	None	1.01A	4qvyY-4fxgH: undetectable 4qvyZ-4fxgH: undetectable	4qvyY-4fxgH: 24.02 4qvyZ-4fxgH: 24.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	6 / 12	HIS H 483 ALA H 633 VAL H 653 TRP H 655 GLY H 656 GLY H 667	None	0.58A	4rn6B-4fxgH: 30.0	4rn6B-4fxgH: 35.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN (Homo sapiens)	5 / 12	GLU G 413 ASP G 415 ASP G 407 GLN G 393 ILE G 392	None	1.08A	4uroA-4fxgG: undetectable	4uroA-4fxgG: 18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZJ8_A_SUVA2001_2 (HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	4 / 6	TRP H 678 ILE H 533 ILE H 497 VAL H 460	None	1.00A	4zj8A-4fxgH: undetectable	4zj8A-4fxgH: 19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JHD_J_EDTJ301_0 (TCRBETA CHAIN)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN (Homo sapiens)	4 / 5	TYR G 410 GLU G 424 GLY G 423 SER G 421	None	1.45A	5jhdJ-4fxgG: undetectable	5jhdJ-4fxgG: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BZO_C_FI8C1201_0 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN (Homo sapiens)	5 / 12	THR G 419 VAL G 411 LYS G 409 VAL G 364 GLU G 333	None	1.02A	6bzoC-4fxgG: undetectable	6bzoC-4fxgG: 8.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJ1_B_AB1B201_0 (HIV-1 PROTEASE)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 12	GLY H 667 GLY H 650 GLY H 651 VAL H 588 ILE H 590	None	0.80A	6dj1A-4fxgH: undetectable	6dj1A-4fxgH: 16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6I5Z_D_SAMD401_0 (O-METHYLTRANSFERASE 1)	4fxg	MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN (Homo sapiens)	5 / 11	GLY H 635 GLY H 470 LEU H 479 VAL H 478 ASP H 532	None	1.26A	6i5zD-4fxgH: undetectable	6i5zD-4fxgH: 22.94

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"HIS H 483;ASP H 627;SER H 628;VAL H 653;GLY H 656;GLY H 667","None","0.56A","1aq7A-4fxgH:32.9","1aq7A-4fxgH:36.18"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ASP H 627;VAL H 653;TRP H 655;GLY H 656;GLY H 667","None","0.37A","1bcuH-4fxgH:36.1","1bcuH-4fxgH:35.23"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"HIS H 483;ASP H 627;VAL H 653;TRP H 655;GLY H 656;GLY H 667","None","0.55A","1etrH-4fxgH:34.7","1etrH-4fxgH:34.47"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ASP H 627;SER H 628;VAL H 653;GLY H 656;GLY H 667","None","0.36A","1f5lA-4fxgH:32.9","1f5lA-4fxgH:31.20"],["1GTI_E_CCSE47_0","GLUTATHIONE S-TRANSFERASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"THR H 670;LEU H 637;GLY H 635;LEU H 479","None","0.99A","1gtiE-4fxgH:undetectable","1gtiE-4fxgH:18.88"],["1OIP_A_VIVA1278_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ILE H 652;ILE H 548;ILE H 536;LEU H 538;VAL H 542","None","1.03A","1oipA-4fxgH:undetectable","1oipA-4fxgH:19.18"],["1SDU_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 619;GLY H 650;GLY H 651;VAL H 588;ILE H 590","None","0.89A","1sduA-4fxgH:undetectable","1sduA-4fxgH:14.88"],["1TNL_A_TPAA900_1","TRYPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ASP H 627;SER H 628;VAL H 653;GLY H 656;GLY H 667","None","0.38A","1tnlA-4fxgH:33.4","1tnlA-4fxgH:36.18"],["2BR4_B_SAMB301_0","CEPHALOSPORIN HYDROXYLASE CMCI","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"LYS H 445;GLY H 631;ASP H 632;ALA H 633;ALA H 481","None","0.91A","2br4B-4fxgH:undetectable","2br4B-4fxgH:23.37"],["2BR4_E_SAME301_0","CEPHALOSPORIN HYDROXYLASE CMCI","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"LYS H 445;GLY H 631;ASP H 632;ALA H 633;ALA H 481","None","0.89A","2br4E-4fxgH:undetectable","2br4E-4fxgH:23.37"],["2F8L_A_SAMA400_0","HYPOTHETICAL PROTEIN LMO1582","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 636;GLY H 470;LEU H 472;VAL H 653;GLY H 651","None","1.12A","2f8lA-4fxgH:undetectable","2f8lA-4fxgH:22.91"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ASP H 627;SER H 628;VAL H 653;GLY H 656;GLY H 667","None","0.33A","2otvA-4fxgH:33.5","2otvA-4fxgH:36.18"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"ASP H 627;VAL H 653;TRP H 655;GLY H 656;GLY H 667;TYR H 669","None","0.32A","2p16A-4fxgH:34.1","2p16A-4fxgH:34.92"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ASP H 627;SER H 628;VAL H 653;GLY H 656;GLY H 667","None","0.41A","2vinA-4fxgH:33.5","2vinA-4fxgH:31.20"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"ASP H 627;VAL H 653;TRP H 655;GLY H 656;GLY H 667;TYR H 669","None","0.35A","2w26A-4fxgH:34.0","2w26A-4fxgH:34.92"],["2Z54_A_AB1A200_1","HIV-1 PROTEASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"GLY H 667;ALA H 619;GLY H 651;VAL H 588;ILE H 590","None","1.05A","2z54A-4fxgH:undetectable","2z54A-4fxgH:17.72"],["3ARU_A_PNXA608_1","CHITINASE A","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"TRP H 573;SER H 571;ALA H 570;ASP H 632","None","1.17A","3aruA-4fxgH:undetectable","3aruA-4fxgH:18.59"],["3EKY_A_DR7A100_1","PROTEASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"GLY H 667;ALA H 619;GLY H 651;VAL H 588;ILE H 590","None","0.95A","3ekyA-4fxgH:undetectable","3ekyA-4fxgH:16.94"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"HIS H 483;ASP H 627;SER H 628;TRP H 655;GLY H 656;GLY H 667","None","0.59A","3gy3A-4fxgH:32.8","3gy3A-4fxgH:36.18"],["3IV6_A_SAMA301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",3,"SER H 493;ASP H 491;ASP H 496","None","0.87A","3iv6A-4fxgH:undetectable","3iv6A-4fxgH:23.43"],["3IV6_C_SAMC301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",3,"SER H 493;ASP H 491;ASP H 496","None","0.93A","3iv6C-4fxgH:undetectable","3iv6C-4fxgH:23.43"],["3KVV_F_URFF254_1","URIDINE PHOSPHORYLASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"GLY H 634;GLN H 459;ILE H 652;VAL H 653","None","1.16A","3kvvF-4fxgH:undetectable","3kvvF-4fxgH:22.65"],["3L8L_D_DVAD8_0","GRAMICIDIN D","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",3,"VAL H 668;VAL H 653;TRP H 655","None","0.89A","3l8lC-4fxgH:undetectable;3l8lD-4fxgH:undetectable","3l8lC-4fxgH:5.45;3l8lD-4fxgH:6.36"],["3N3I_A_ROCA201_1","PROTEASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 633;ASP H 632;GLY H 470;ASP H 532;ALA H 482","None","1.22A","3n3iA-4fxgH:undetectable","3n3iA-4fxgH:23.17"],["3NVK_I_SAMI228_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"LYS H 445;GLY H 635;ILE H 652;ALA H 481;ASP H 632","None","1.05A","3nvkI-4fxgH:undetectable","3nvkI-4fxgH:22.06"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"SER H 628;VAL H 653;TRP H 655;GLY H 656;GLY H 667","None","0.44A","3rxfA-4fxgH:14.4","3rxfA-4fxgH:36.18"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"ASP H 627;SER H 628;VAL H 653;GLY H 667","None","0.40A","3rxhA-4fxgH:33.4","3rxhA-4fxgH:36.18"],["4FFW_A_715A801_2","DIPEPTIDYL PEPTIDASE 4","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",3,"PHE H 529;TYR H 486;TYR H 523","None","1.00A","4ffwA-4fxgH:undetectable","4ffwA-4fxgH:15.99"],["4GBO_B_CUB301_0","E7","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"HIS H 525;ALA H 484;HIS H 483;TYR H 523","None","1.43A","4gboB-4fxgH:undetectable","4gboB-4fxgH:19.29"],["4HFP_D_15UD402_1","PROTHROMBIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"HIS H 483;ASP H 627;ALA H 633;VAL H 653;TRP H 655;GLY H 667","None","0.54A","4hfpD-4fxgH:35.0","4hfpD-4fxgH:35.61"],["4J24_A_ESTA600_1","ESTROGEN RECEPTOR BETA","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"LEU H 473;LEU H 472;LEU H 538;ILE H 679;ILE H 682","None","1.13A","4j24A-4fxgH:undetectable","4j24A-4fxgH:20.07"],["4J24_B_ESTB600_1","ESTROGEN RECEPTOR BETA","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"LEU H 473;LEU H 472;LEU H 538;ILE H 679;ILE H 682","None","1.11A","4j24B-4fxgH:undetectable","4j24B-4fxgH:20.07"],["4Q5M_A_ROCA1101_2","PROTEASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 481;ILE H 652;GLY H 470;VAL H 517;ILE H 536","None","0.99A","4q5mA-4fxgH:undetectable","4q5mA-4fxgH:22.36"],["4QVY_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 484;ALA H 469;ALA H 633;GLY H 464;THR H 466","None","1.03A","4qvyK-4fxgH:undetectable;4qvyL-4fxgH:undetectable","4qvyK-4fxgH:24.02;4qvyL-4fxgH:24.33"],["4QVY_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"ALA H 484;ALA H 469;ALA H 633;GLY H 464;THR H 466","None","1.01A","4qvyY-4fxgH:undetectable;4qvyZ-4fxgH:undetectable","4qvyY-4fxgH:24.02;4qvyZ-4fxgH:24.33"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",6,"HIS H 483;ALA H 633;VAL H 653;TRP H 655;GLY H 656;GLY H 667","None","0.58A","4rn6B-4fxgH:30.0","4rn6B-4fxgH:35.45"],["4URO_A_NOVA2000_1","DNA GYRASE SUBUNIT B","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN","Homo sapiens",5,"GLU G 413;ASP G 415;ASP G 407;GLN G 393;ILE G 392","None","1.08A","4uroA-4fxgG:undetectable","4uroA-4fxgG:18.45"],["4ZJ8_A_SUVA2001_2","HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",4,"TRP H 678;ILE H 533;ILE H 497;VAL H 460","None","1.00A","4zj8A-4fxgH:undetectable","4zj8A-4fxgH:19.55"],["5JHD_J_EDTJ301_0","TCRBETA CHAIN","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN","Homo sapiens",4,"TYR G 410;GLU G 424;GLY G 423;SER G 421","None","1.45A","5jhdJ-4fxgG:undetectable","5jhdJ-4fxgG:20.63"],["6BZO_C_FI8C1201_0","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 A CHAIN","Homo sapiens",5,"THR G 419;VAL G 411;LYS G 409;VAL G 364;GLU G 333","None","1.02A","6bzoC-4fxgG:undetectable","6bzoC-4fxgG:8.60"],["6DJ1_B_AB1B201_0","HIV-1 PROTEASE","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"GLY H 667;GLY H 650;GLY H 651;VAL H 588;ILE H 590","None","0.80A","6dj1A-4fxgH:undetectable","6dj1A-4fxgH:16.24"],["6I5Z_D_SAMD401_0","O-METHYLTRANSFERASE 1","4fxg","MANNAN-BINDING LECTIN SERINE PROTEASE 2 B CHAIN","Homo sapiens",5,"GLY H 635;GLY H 470;LEU H 479;VAL H 478;ASP H 532","None","1.26A","6i5zD-4fxgH:undetectable","6i5zD-4fxgH:22.94"]]